DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24
09. Oktober 2024 08:00 ET
|
Daxor Corporation
Elite Cardiovascular Leaders Unite: Driving Innovation Through Shared Excellence Oak Ridge, TN, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume...
Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
18. Juni 2024 08:00 ET
|
Daxor Corporation
Oak Ridge, TN, June 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit at the American...
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress
16. Januar 2024 08:00 ET
|
Daxor Corporation
Oak Ridge, TN, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the Society for...
New Randomized Controlled Trial Demonstrates the Efficacy of Daxor’s BVA Guided-Care in Heart Failure Patients
13. November 2023 08:00 ET
|
Daxor Corporation
Data From Study Funded by NIH Presented at the American Heart Association Annual Meeting Oak Ridge, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...
Daxor Corporation Awarded New Patent for Remote Monitoring of Blood Volume
09. November 2023 08:00 ET
|
Daxor Corporation
Patent Covers Novel Optimization of Care by Remote Monitoring Devices Including Smartwatches Oak Ridge, TN, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in...
Expert Panelists Advocate Use of Daxor’s Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific Meeting
13. Oktober 2023 08:00 ET
|
Daxor Corporation
Leading Clinicians Highlight Significant Outcome Improvements with Daxor’s Blood Volume Analysis Innovative Technology Oak Ridge, TN, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq:...
New Data from Banner University Medicine Demonstrating Effectiveness of BVA-100® Use in Ambulatory Heart Failure Patients Presented at Heart Failure Society of America Annual Scientific Meeting
11. Oktober 2023 08:00 ET
|
Daxor Corporation
Blood Volume Analysis (BVA) in 83-Patient Study Provided Highly Effective Guidance for Care of Heart Failure Patients Otherwise Unavailable Using Common Proxy Diagnostic Methods Oak Ridge, TN, Oct. ...
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023
27. September 2023 08:00 ET
|
Daxor Corporation
Daxor’s Blood Volume Technology Featured at Scientific Session Oak Ridge, TN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement...
DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL’23 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)
26. September 2023 08:00 ET
|
Daxor Corporation
The Premier Event for The Cardiovascular Industry's Leading Network of Executives and Clinicians - Transforming Cardiovascular Care Through Sharing Best Practices and Organizational Performance...
JACC-HF Reports Successful Heart Failure Trial With Daxor BVA-100®
10. August 2023 08:00 ET
|
Daxor Corporation
Researchers Call for Larger Clinical Trial Citing Outcomes from Study Oak Ridge, TN, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume...